Chandra Bhagat Pharma Ltd vs Sunrest Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Chandra Bhagat Pharma Ltd is ₹ 33 as of 27 Apr 15:30 . The P/E Ratio of Chandra Bhagat Pharma Ltd changed from 158.4 on March 2021 to 45.9 on March 2025 . This represents a CAGR of -21.94% over 5 yearsThe P/E Ratio of Sunrest Lifescience Ltd changed from 115.2 on March 2024 to 11.5 on March 2025 . This represents a CAGR of -68.40% over 2 years The Market Cap of Chandra Bhagat Pharma Ltd changed from ₹ 29.88 crore on March 2021 to ₹ 39.48 crore on March 2025 . This represents a CAGR of 5.73% over 5 yearsThe Market Cap of Sunrest Lifescience Ltd changed from ₹ 26.2 crore on March 2024 to ₹ 23.07 crore on March 2025 . This represents a CAGR of -6.16% over 2 years The Dividend Payout of Chandra Bhagat Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sunrest Lifescience Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10, 2003.
Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20, 2019. The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late.
Shree Chandravadan Bhagat.
On April 1, 2003, the Company acquired the going concern business of M/s.
Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities.

About Sunrest Lifescience Ltd

Sunrest Lifescience Limited was originally incorporated as 'Sunrest Lifescience Private Limited' as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited' on March 21, 2023. The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market.
The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan.
It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste.
Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

FAQs for the comparison of Chandra Bhagat Pharma Ltd and Sunrest Lifescience Ltd

Which company has a larger market capitalization, Chandra Bhagat Pharma Ltd or Sunrest Lifescience Ltd?

Market cap of Chandra Bhagat Pharma Ltd is 24 Cr while Market cap of Sunrest Lifescience Ltd is 30 Cr

What are the key factors driving the stock performance of Chandra Bhagat Pharma Ltd and Sunrest Lifescience Ltd?

The stock performance of Chandra Bhagat Pharma Ltd and Sunrest Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chandra Bhagat Pharma Ltd and Sunrest Lifescience Ltd?

As of May 3, 2026, the Chandra Bhagat Pharma Ltd stock price is INR ₹33.0. On the other hand, Sunrest Lifescience Ltd stock price is INR ₹36.1.

How do dividend payouts of Chandra Bhagat Pharma Ltd and Sunrest Lifescience Ltd compare?

To compare the dividend payouts of Chandra Bhagat Pharma Ltd and Sunrest Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.